UBS Group’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,949
| Closed | -$693K | – | 7422 |
|
|
2018
Q4 | $693K | Buy |
4,949
+364
| +8% | +$51K | ﹤0.01% | 3275 |
|
|
2018
Q3 | $783K | Sell |
4,585
-10,740
| -70% | -$1.83M | ﹤0.01% | 3340 |
|
|
2018
Q2 | $2.66M | Sell |
15,325
-12,701
| -45% | -$2.2M | ﹤0.01% | 2328 |
|
|
2018
Q1 | $3.23M | Buy |
28,026
+15,308
| +120% | +$1.77M | ﹤0.01% | 2188 |
|
|
2017
Q4 | $1.07M | Sell |
12,718
-8,772
| -41% | -$739K | ﹤0.01% | 2974 |
|
|
2017
Q3 | $1.98M | Sell |
21,490
-12,264
| -36% | -$1.13M | ﹤0.01% | 2501 |
|
|
2017
Q2 | $2.71M | Buy |
33,754
+32,539
| +2,678% | +$2.61M | ﹤0.01% | 2166 |
|
|
2017
Q1 | $51K | Sell |
1,215
-66
| -5% | -$2.77K | ﹤0.01% | 4626 |
|
|
2016
Q4 | $42K | Sell |
1,281
-385
| -23% | -$12.6K | ﹤0.01% | 5048 |
|
|
2016
Q3 | $44K | Buy |
1,666
+1,181
| +244% | +$31.2K | ﹤0.01% | 4759 |
|
|
2016
Q2 | $11K | Hold |
485
| – | – | ﹤0.01% | 5858 |
|
|
2016
Q1 | $13K | Buy |
+485
| New | +$13K | ﹤0.01% | 5671 |
|
|
2015
Q4 | – | Sell |
-74
| Closed | -$1K | – | 7117 |
|
|
2015
Q3 | $1K | Sell |
74
-1,753
| -96% | -$23.7K | ﹤0.01% | 6753 |
|
|
2015
Q2 | $33K | Buy |
+1,827
| New | +$33K | ﹤0.01% | 5102 |
|
|
2015
Q1 | – | Sell |
-399
| Closed | -$5K | – | 6918 |
|
|
2014
Q4 | $5K | Buy |
+399
| New | +$5K | ﹤0.01% | 6375 |
|